What is Vor Biopharma Inc. Common Stock's Market Cap?

Vor Biopharma Inc. Common Stock's Market Cap is $1.5B, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's Enterprise Value?

Vor Biopharma Inc. Common Stock's Enterprise Value is $1.0B, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's Trailing P/E?

Vor Biopharma Inc. Common Stock's Trailing P/E is 2.4×, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's EV / EBITDA?

Vor Biopharma Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's Net Income (TTM)?

Vor Biopharma Inc. Common Stock's Net Income (TTM) is $627.8M, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's EBITDA?

Vor Biopharma Inc. Common Stock's EBITDA is -$147.0M, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's Diluted EPS (TTM)?

Vor Biopharma Inc. Common Stock's Diluted EPS (TTM) is 10.61, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's Net Debt?

Vor Biopharma Inc. Common Stock's Net Debt is -$466.1M, based on as-reported figures from SEC (XBRL) filings.

Vor Biopharma Inc. Common Stock (VOR) Financial Statements

Vor Biopharma Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00NBJRDV3

XNAS · usd

25.02▼ 0.08 (-0.32%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close25.10

Day's Range24.10 – 26.00

52-Week Range1.46 – 49.95

Volume856.1K

Avg Volume750.0K

Share Statistics

Shares Outstanding

Employees168

ExchangeXNAS

Listed2021-02-05

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Vor Biopharma Inc. Common Stock (VOR)

What is Vor Biopharma Inc. Common Stock's Market Cap?: Vor Biopharma Inc. Common Stock's Market Cap is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's Enterprise Value?: Vor Biopharma Inc. Common Stock's Enterprise Value is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's Trailing P/E?: Vor Biopharma Inc. Common Stock's Trailing P/E is 2.4×, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's EV / EBITDA?: Vor Biopharma Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's Net Income (TTM)?: Vor Biopharma Inc. Common Stock's Net Income (TTM) is $627.8M, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's EBITDA?: Vor Biopharma Inc. Common Stock's EBITDA is -$147.0M, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's Diluted EPS (TTM)?: Vor Biopharma Inc. Common Stock's Diluted EPS (TTM) is 10.61, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's Net Debt?: Vor Biopharma Inc. Common Stock's Net Debt is -$466.1M, based on as-reported figures from SEC (XBRL) filings.